Answers are grounded in this paper and cite their sources.
Spinal muscular atrophy (SMA) is an autosomal recessive motor neuron disorder caused by biallelic abnormalities of the survival motor neuron 1 (SMN1) gene, with phenotype modified in part by SMN2 copy number. The estimated incidence is approximately 1 in 10,000 live births, although estimates vary between populations. SMA type 3 presents after independent walking has been achieved and may cause progressive proximal weakness, falls, difficulty rising from the floor, and gait abnormalities. Delayed diagnosis remains clinically relevant despite the availability of molecular testing and disease-modifying therapies. Published reports have described children initially managed for hypotonia, gait abnormalities, orthopedic problems, or other neuromuscular diagnoses before SMA was recognized. This case is publishable because it combines several educationally important features. The diagnostic delay following an initial orthopedic label of bilateral club feet, despite having a similarly affected older sibling, indicate the lack of knowledge and clinical correlation. It therefore illustrates a clinically relevant diagnostic pathway, particularly for resource-limited settings, rather than simply documenting a rare genetic result. This article report a 12-year-old boy who had progressive difficulty walking since the age of 18 months, after achieving independent walking. He initially fell after walking short distances and developed difficulty rising from sitting, followed by difficulty climbing stairs, running, and jumping as his age progresses. At about 3 years he was reportedly diagnosed with bilateral club feet and treated with corrective shoes without improvement. Follow-up was later interrupted due to lack of improvement. The mother mentioned that the patient use his hands to crawl and stand. His 27-year-old brother had a similar early-onset progressive motor disorder and became wheelchair dependent. Examination showed exaggerated lumbar lordosis, generalized hypotonia, absent deep tendon reflexes, proximal lower-limb weakness with preserved distal strength, waddling gait, positive Gowers sign, and tongue fasciculation without atrophy. Sensation was intact. EMG showed mixed neurogenic and myogenic changes and NCS severe bilateral tibial axonal neuropathy. Molecular testing demonstrated homozygous deletion of SMN1 exon 7 and heterozygous deletion of exon 8, supporting 5q SMA, clinically consistent with SMA type 3. This case report shows that physicians should consider SMA in patients presented with progressive gait difficulty after acquisition of independent walking, especially when accompanied by proximal weakness, hypotonia, areflexia, Gowers sign and preserved sensation. Early recognition and molecular confirmation are increasingly important because disease-modifying therapies and multidisciplinary care have changed SMA management.
No takes yet. Share an insight, caveat, or question.
Amare et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: